Schott Pharma AG KGaA (CHIX:1SXPD) EV-to-Revenue : 4.51 (As of Jun. 03, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Schott Pharma AG KGaA's enterprise value is €4,308.7 Mil. Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €954.7 Mil. Therefore, Schott Pharma AG KGaA's EV-to-Revenue for today is 4.51.

The historical rank and industry rank for Schott Pharma AG KGaA's EV-to-Revenue or its related term are showing as below:

CHIX:1SXPd' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.38 Med: 4.84 Max: 6.8
Current: 4.51

During the past 5 years, the highest EV-to-Revenue of Schott Pharma AG KGaA was 6.80. The lowest was 3.38. And the median was 4.84.

CHIX:1SXPd's EV-to-Revenue is ranked worse than
62.74% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.09 vs CHIX:1SXPd: 4.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Schott Pharma AG KGaA's stock price is €22.80. Schott Pharma AG KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €6.35. Therefore, Schott Pharma AG KGaA's PS Ratio for today is 3.59.

Schott Pharma AG KGaA EV-to-Revenue Historical Data

The historical data trend for Schott Pharma AG KGaA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA EV-to-Revenue Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

EV-to-Revenue

5.36

4.89

Schott Pharma AG KGaA Quarterly Data
	Sep20	Sep21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial							5.55	6.56	4.83	4.89	3.95

Competitive Comparison of Schott Pharma AG KGaA's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Schott Pharma AG KGaA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Schott Pharma AG KGaA's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4308.693	/	954.681
	=	4.51

Schott Pharma AG KGaA's current Enterprise Value is €4,308.7 Mil.
Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €954.7 Mil.

Schott Pharma AG KGaA (CHIX:1SXPd) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Schott Pharma AG KGaA's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	22.80	/	6.351
	=	3.59

Schott Pharma AG KGaA's share price for today is €22.80.
Schott Pharma AG KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €6.35.

Schott Pharma AG KGaA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SHTPY:USA 1SXP:Italy 1SXP:Germany 1SXP:Austria

Address

Hattenbergstrasse 10, Mainz, RP, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines